K. Paricaud
University of Toulouse
16 Papers
10 Citations
K. Paricaud is an academic researcher from University of Toulouse. The author has contributed to research in topics: Cancer & Internal medicine. The author has an hindex of 2, co-authored 16 publications.
Chat about Author
Papers
High rate of indeterminate results of the QuantiFERON-TB Gold in-tube test, third generation, in patients with systemic vasculitis
Stella Rousset,Emmanuel Treiner,Emmanuel Treiner,G. Moulis,Grégory Pugnet,Leonardo Astudillo,K. Paricaud,Bénédicte Puissant-Lubrano,Bénédicte Puissant-Lubrano,Philippe Arlet,Antoine Blancher,Antoine Blancher,Laurent Sailler +12 more
TL;DR: The results question the reliability of QFT-GIT to rule out latent tuberculosis in vasculitis patients at diagnosis, prior to immunosuppressant therapy.
Digital necrosis revealing localized polyarteritis nodosa.
K. Paricaud,Grégory Pugnet,Guillaume Moulis,Philippe Arlet,Leonardo Astudillo,Laurent Sailler +5 more
TL;DR: Hematological malignancy associated with polymyositis and dermatomyositis: a population-based study.
2
Pulmonary mucormycosis following autologous hematopoietic stem cell transplantation for rapidly progressive diffuse cutaneous systemic sclerosis: A case report.
Xavier Boumaza,Lucie Lelièvre,Sarah Guenounou,Cécile Borel,Anne Huynh,Guillaume Beziat,Karen Delavigne,Damien Guinault,Marie Garric,Marie Piel-Julian,K. Paricaud,Guillaume Moulis,Leonardo Astudillo,Laurent Sailler,Dominique Farge,Grégory Pugnet +15 more
TL;DR: With the progressively increasing use of AHSCT and other stem cell therapy for treatment of severe SSc and other autoimmune diseases, the potential onset of rare post-transplant fungal infections, such as mucormycosis, requires careful patient monitoring and better awareness of early initiation of adequate therapy.
1
TAFRO syndrome and cutaneous necrotizing vasculitis
J. Maquet,E. Bories,M.B. Nogier,C. Beck,G. Aizel,A. Toledano,Stanislas Faguer,K. Paricaud,Grégory Pugnet,Guillaume Moulis,Leonardo Astudillo,Laurent Sailler +11 more
TL;DR: Le syndrome TAFRO peut s’associer a une vascularite necrosante cutanee, la resistance possible au tocilizumab merite d’etre connue.
1